The Relevance of Pharmacokinetic Biomarkers in Response to Methadone Treatment: A Systematic Review.  Recarey-Rama S, Gómez-Trigo J, Gil-Rodriguez A, Dominguez E, Sánchez-Martínez I, Riveiro-Recimil Á, Barral-Raña A, de Leon J, Rodriguez-Viyue…

Selective Serotonin Reuptake Inhibitors and Risk of Serotonin Syndrome as Consequence of Drug-Drug Interactions: analysis of The FDA Adverse Event Reporting System (FAERS).  Novella A, Elli C, Pasina L.  Med Princ Pract. 2025 Apr 25:1-12…

An Overview of the Potential for Pharmacokinetic Interactions Between Drugs and Cannabis Products in Humans.  Caicedo DA, Pérez-Mañá C, Farré M, Papaseit E. Pharmaceutics. 2025 Mar 1;17(3):319. doi: 10.3390/pharmaceutics17030319. PMID: 401429…

Risk of Opioid Overdose Associated with Concomitant Use of Methadone and Statins.  Chen, C., Miano, T.A., Brensinger, C.M., Leonard, C.E., Bilker, W.B. and Hennessy, S. (2025),  Clin Pharmacol Ther, 117: 421-426. doi.org/10.1002/cpt.3479…

Leveraging Real-World Data to Address Potential Methadone Drug-Drug Interactions.  Holstein SA.  Clin Pharmacol Ther. 2025 Feb;117(2):321-323. doi: 10.1002/cpt.3520. PMID: 39821205. https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt…

Drug interactions in a sample of inpatients diagnosed with cannabis use disorder.  Schulze Westhoff M, Massarou C, Bleich S, Heck J, Jendretzky KF, Glahn A, Schröder S. J Neural Transm (Vienna). 2025 Jan 23. doi: 10.1007/s00702-025-02884-5. E…